XTL Biopharmaceuticals Ltd. Operating Cycle | XTLB

Annual Operating Cycle XTL Biopharmaceuticals Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	214	269	-

All numbers in USD currency

Maximum	Minimum	Average
269	214	242

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Fate Therapeutics FATE	122	$ 1.78	-8.51 %	$ 211 M	USA
Halozyme Therapeutics HALO	347	$ 103.0	0.08 %	$ 12.3 B	USA
Hutchison China MediTech Limited HCM	144	$ 15.34	0.1 %	$ 13.2 B	China
Aptorum Group Limited APM	106	-	-	$ 5.72 M	China
iBio IBIO	3.46 K	$ 0.78	-1.89 %	$ 81.2 M	USA
Karyopharm Therapeutics KPTI	71.2	$ 0.02	-54.5 %	$ 219	USA
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Catalyst Pharmaceuticals CPRX	178	-	-	$ 3.85 B	USA
UroGen Pharma Ltd. URGN	465	$ 25.32	-3.78 %	$ 1.22 B	Israel
Catalyst Biosciences CBIO	293	$ 13.91	1.9 %	$ 1.24 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
ADiTx Therapeutics ADTX	8.01 K	-	-	$ 374	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Apellis Pharmaceuticals APLS	115	-	-	$ 5.18 B	USA
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	419	-	0.49 %	$ 251 B	Cayman-islands
EyePoint Pharmaceuticals EYPT	7.32	$ 0.39	9.06 %	$ 28.6 K	USA
Cara Therapeutics CARA	81.1	-	-3.03 %	$ 260 M	USA
ChromaDex Corporation CDXC	142	-	-0.88 %	$ 598 M	USA
Caladrius Biosciences CLBS	966	-	-16.75 %	$ 25.8 M	USA
Cyclacel Pharmaceuticals CYCC	185	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
Diffusion Pharmaceuticals DFFN	69.1	-	11.68 %	$ 8.97 M	USA
Esperion Therapeutics ESPR	99.7	-	-	$ 661 M	USA
Evofem Biosciences EVFM	309	-	7.55 %	$ 38.1 M	USA
Eyenovia EYEN	5.1	-	49.81 %	$ 13.2 M	USA
FibroGen FGEN	2.28 K	-	-	$ 889 M	USA
Amicus Therapeutics FOLD	932	-	-	$ 4.47 B	USA
GlycoMimetics GLYC	303	-	9357.83 %	$ 1.01 B	USA